5,341
Views
18
CrossRef citations to date
0
Altmetric
Review

Real-world research and the role of observational data in the field of gynaecology – a practical review

, &
Pages 250-259 | Received 27 Apr 2017, Accepted 25 Jul 2017, Published online: 17 Aug 2017

References

  • Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence – what is it and what can it tell us? N Engl J Med. 2016;375:2293–2297.
  • Dreyer NA, Bryant A, Velentgas P, et al. The GRACE checklist: a validated assessment tool for high quality observational studies of comparative effectiveness. JMCP. 2016;22:1107–1113.
  • CEBM.net [Internet]. Oxford: Centre for Evidence-Based Medicine; [cited 2017 Feb 26]. Available from: http://www.cebm.net/study-designs/
  • CHCUK.co.uk [Internet]. Contin: What are pragmatic clinical trials?; 2015. [cited 2017 Mar 17]. Available from: http://www.chcuk.co.uk/wp-content/uploads/2015/11/2015-11-22_Pragmatic-Clinical-Trials_CHCUK1.pdf
  • NPCNOW.org [Internet]. Washington: National Pharmaceutical Council. Making informed decisions: assessing the strengths and weaknesses of study designs and analytic methods for comparative effectiveness research. Velengtas P, Mohr P, Messner DA, editors. 2012 February [cited 2017 Mar 19]. Available from: http://www.npcnow.org/system/files/research/download/experimental_nonexperimental_study_final.pdf
  • OUP. Oxford; Oxford University Press. In: Smith PG, Morrow RH, Ross DA, editors. Field Trials of Health Interventions: A Toolbox. 3rd ed.; 2015 Jun 1. Chapter 1, Introduction to field trials of health interventions [cited 2017 Mar 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305510/
  • Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515.
  • Cai T, Zheng Y. Evaluating prognostic accuracy of biomarkers in nested case-control studies. Biostatistics. 2012;13:89–100.
  • Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878–1886.
  • Concato J. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887–1892.
  • CEBM.net [Internet]. Oxford: Centre for Evidence-Based Medicine; [cited 2017 Feb 26]. Available from: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/
  • Hernán MA. With great data comes great responsibility: publishing comparative effectiveness research in epidemiology. Epidemiology. 2011;22:290–291.
  • Amarasingham R, Audet AM, Bates DW, et al. Consensus statement on electronic health predictive analytics: a guiding framework to address challenges. EGEMS (Wash DC). 2016;4:1163.
  • Andrews EB, Margulis AV, Tennis P, et al. Opportunities and challenges in using epidemiologic methods to monitor drug safety in the era of large automated health databases. Curr Epidemiol Rep. 2014;1:194–205.
  • Etheredge LM. A rapid-learning health system. Health Aff (Millwood). 2007;26:w107–w118.
  • Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183:758–764.
  • Hershman DL, Wright JD. Comparative effectiveness research in oncology methodology: observational data. J Clin Oncol. 2012;30:4215–4222.
  • Kaggal VC, Elayavilli RK, Mehrabi S, et al. Toward a learning health-care system – knowledge delivery at the point of care empowered by big data and NLP. Biomed Inform Insights. 2016;8:13–22.
  • Dreyer NA. Making observational studies count; shaping the future of comparative effectiveness research. Epidemiology. 2011;22:295–297.
  • Dreyer NA, Tunis SR, Berger M, et al. Why observational studies should be among the tools used in comparative effectiveness research. Health Affairs. 2010;29:1818–1825.
  • Hannaford PC, Iversen L, Macfarlane TV, et al. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study. BMJ.2010;340:c927
  • Iversen L, Sivasubramaniam S, Lee AJ, et al. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study. Am J Obstet Gynecol. 2017;216:580.e1–580.e9.
  • Charlton M, Rich-Edwards JW, Colditz GA, et al. Oral contraceptive use and mortality after 36 years of follow-up in the Nurses’ Health Study: prospective cohort study. BMJ. 2014;349:g6356.
  • Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107:103–111.
  • Cadeau C, Fournier A, Mesrine S, et al. Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort. Am J Clin Nutr. 2015;102:966–973.
  • Virkus RA, Løkkegaard E, Lidegaard Ø, et al. Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort. PLoS One. 2014;9:e96495.
  • Dinger J, Do Minh T, Heinemann K. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception. 2016;94:328–339.
  • Cea Soriano L, Asiimwe A, García Rodríguez LA. Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network. Contraception. 2017;95:299–305.
  • Cea Soriano L, Wallander MA, Andersson S, et al. The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network. Pharmacoepidemiol Drug Saf. 2015;24:52–58.
  • Heikinheimo O, Gissler M, Suhonen S. Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion. Contraception. 2008;78:149–154.
  • Tolsgaard MG, Rasmussen MB, Tappert C, et al. Which factors are associated with trainees' confidence in performing obstetric and gynecological ultrasound examinations?. Ultrasound Obstet Gynecol. 2014;43:444–451.
  • Ludvigsson JF, Ström P, Lundholm C, et al. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. BMJ. 2015;351:h5585.
  • RCGPOCS. Oral contraceptives, venous thrombosis, and varicose veins. Royal College of General Practitioners' Oral Contraception Study. J R Coll Gen Pract. 1978;28:393–399.
  • Leung VW, Soon JA, Lynd LD, et al. Population-based evaluation of the effectiveness of two regimens for emergency contraception. Int J Gynaecol Obstet. 2016;133:342–346.
  • Cottreau CM, Ness RB, Modugno F, et al. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. Clin Cancer Res. 2003;9:5142–5144.
  • Skovlund CW, Mørch LS, Kessing LV, et al. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73:1154–1162.
  • Delgado-Rodríguez M, Llorca J. Bias. J Epidemiol Community Health. 2004;58:635–641.
  • Hernán MA, Hernández-Díaz S, Werler MM, et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002;155:176–184.
  • Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol. 1999;149:981–983.
  • Martín-Merino E, Wallander MA, Andersson S, et al. The reporting and diagnosis of uterine fibroids in the UK: an observational study. BMC Womens Health. 2016;16:45.
  • Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the general practice research database: a systematic review. Br J Gen Pract. 2010;60:e128–e136.
  • Hall GC, Sauer B, Bourke A, et al. Guidelines for good database selection and use in pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2012;21:1–10.
  • NIHcollaboratory.org [Internet]. Durham: National Institutes of Health Collaboratory. Assessing data quality for healthcare systems data used in clinical research (version 1.0). Zozus MN, Ed Hammond W, Green BB, et al. 2014 [cited 2017 Apr 18]. Available from: https://www.nihcollaboratory.org/Products/Assessing-data-quality_V1%200.pdf
  • García Rodríguez LA, Ruigómez A. Case validation in research using large databases. Br J Gen Pract. 2010;60:160–161.
  • Tate AR, Martin AG, Ali A, et al. Using free text information to explore how and when GPs code a diagnosis of ovarian cancer: an observational study using primary care records of patients with ovarian cancer. BMJ Open. 2011;1:e000025.
  • AHRQ Publication No. 12(13)-EHC099. Rockville; Agency for Healthcare Research and Quality. In: Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, editors. Developing a protocol for observational comparative effectiveness research: a user’s guide; 2013. [cited 2017 Feb 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK126190/
  • ENCePP.eu [Internet]. London: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Checklist for study protocols (revision 3). [cited 2017 Feb 26]. Available from: http://www.encepp.eu/standards_and_guidances/checkListProt-ocols.shtml
  • ENCePP.eu [Internet]. London: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Guide on methodological standards in pharmacoepidemiology (Revision 5). EMA/95098/2010. [cited 2017 Feb 26]. Available from: http://www.encepp.eu/standards_and_guidances/method-ologicalGuide.shtml
  • Berger ML, Mamdani M, Atkins D, et al. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR good research practices for retrospective database analysis task force report – Part I. Value Health. 2009;12:1044–1052.
  • Cox E, Martin BC, Van Staa T, et al. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research good research practices for retrospective database analysis task force report – Part II. Value Health. 2009;12:1053–1061.
  • Johnson ML, Crown W, Martin BC, et al. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR good research practices for retrospective database analysis task force report – Part III. Value Health. 2009;12:1062–1073.
  • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349.
  • de Groot M, van der Wouden JM, van Hell EA, et al. Evidence-based practice for individuals or groups: let's make a difference. Perspect Med Educ. 2013;2:216–221.